The purpose of this study is to evaluate whether statin is effective in the treatment of vasospastic angina.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
20mg QD
Placebo drug will be administered.
Asan Medical Center
Seoul, Songpa-gu, South Korea
The Composite Event of all-cause death, myocardial infarction, angina-related hospitalization
The number of events with the first occurrence of a composite event(all-cause death, myocardial infarction, angina-related hospitalization)
Time frame: 3 years
all-cause death
Time frame: 3 years
cardiac death
Time frame: 3 years
cardiac arrest
Time frame: 3 years
myocardial infarction
Time frame: 3 years
angina-related hospitalization
Time frame: 3 years
Composite event of death or myocardial infarction
Time frame: 3 years
Composite event of cardiac death or myocardial infarction
Time frame: 3 years
statin-related complications
event rate of statin-related complications
Time frame: 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.